Search Results - "ROOT, Michael J"
-
1
Receptor Activation of HIV-1 Env Leads to Asymmetric Exposure of the gp41 Trimer
Published in PLoS pathogens (19-12-2016)“…Structural rearrangements of HIV-1 glycoprotein Env promote viral entry through membrane fusion. Env is a symmetric homotrimer with each protomer composed of…”
Get full text
Journal Article -
2
Regulation of epitope exposure in the gp41 membrane-proximal external region through interactions at the apex of HIV-1 Env
Published in PLoS pathogens (01-05-2022)“…Glycoprotein Env of human immunodeficiency virus type 1 (HIV-1) mediates viral entry through membrane fusion. Composed of gp120 and gp41 subunits arranged as a…”
Get full text
Journal Article -
3
Design of a Potent d-Peptide HIV-1 Entry Inhibitor with a Strong Barrier to Resistance
Published in Journal of Virology (01-11-2010)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
4
Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators
Published in Retrovirology (09-10-2021)“…We previously developed drug-like peptide triazoles (PTs) that target HIV-1 Envelope (Env) gp120, potently inhibit viral entry, and irreversibly inactivate…”
Get full text
Journal Article -
5
Interactions of HIV-1 Inhibitory Peptide T20 with the gp41 N-HR Coiled Coil
Published in The Journal of biological chemistry (06-02-2009)“…Cellular entry of human immunodeficiency virus type 1 (HIV-1) involves fusion of viral and cellular membranes and is mediated by structural transitions in…”
Get full text
Journal Article -
6
Potent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus
Published in PLoS pathogens (01-11-2016)“…HIV-1 entry can be inhibited by soluble peptides from the gp41 heptad repeat-2 (HR2) domain that interfere with formation of the 6-helix bundle during fusion…”
Get full text
Journal Article -
7
Characterization of resistance to a potent D-peptide HIV entry inhibitor
Published in Retrovirology (22-10-2019)“…PIE12-trimer is a highly potent D-peptide HIV-1 entry inhibitor that broadly targets group M isolates. It specifically binds the three identical conserved…”
Get full text
Journal Article -
8
Kinetic Dependence to HIV-1 Entry Inhibition
Published in The Journal of biological chemistry (01-09-2006)“…Infection by human immunodeficiency virus type 1 (HIV-1) involves the fusion of viral and cellular membranes mediated by formation of the gp41…”
Get full text
Journal Article -
9
Asymmetric deactivation of HIV-1 gp41 following fusion inhibitor binding
Published in PLoS pathogens (01-11-2009)“…Both equilibrium and nonequilibrium factors influence the efficacy of pharmaceutical agents that target intermediate states of biochemical reactions. We…”
Get full text
Journal Article -
10
Nucleoporin Nup50 Stabilizes Closed Conformation of Armadillo repeat 10 in Importin α5
Published in The Journal of biological chemistry (13-01-2012)“…The human genome encodes six isoforms of importin α that show greater than 60% sequence similarity and remarkable substrate specificity. The isoform importin…”
Get full text
Journal Article -
11
Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain
Published in PloS one (20-08-2008)“…Botulinum neurotoxins (BoNT) are a family of category A select bioterror agents and the most potent biological toxins known. Cloned antibody therapeutics hold…”
Get full text
Journal Article -
12
Complex interplay of kinetic factors governs the synergistic properties of HIV-1 entry inhibitors
Published in The Journal of biological chemistry (06-10-2017)“…The homotrimeric HIV-1 envelope glycoprotein (Env) undergoes receptor-triggered structural changes that mediate viral entry through membrane fusion. This…”
Get full text
Journal Article -
13
Hybridoma populations enriched for affinity-matured human IgGs yield high-affinity antibodies specific for botulinum neurotoxins
Published in Journal of immunological methods (20-04-2008)“…The affinity-matured human antibody repertoire may be ideal as a source for antibody therapeutics against infectious diseases and bioterror agents. Hybridoma…”
Get full text
Journal Article -
14
Polyvalent Side Chain Peptide–Synthetic Polymer Conjugates as HIV-1 Entry Inhibitors
Published in Biomacromolecules (14-05-2012)“…This report describes the synthesis and properties of a series of polyvalent side chain peptide–synthetic polymer conjugates designed to block the CD4 binding…”
Get full text
Journal Article -
15
Targeting Therapeutics to an Exposed and Conserved Binding Element of the HIV-1 Fusion Protein
Published in Proceedings of the National Academy of Sciences - PNAS (29-04-2003)“…There is an urgent need for new drugs that can kill HIV type 1 (HIV-1)-infected cells. HIV-1 glycoprotein Env, which promotes viral membrane fusion through…”
Get full text
Journal Article -
16
Lithium–manganese dioxide cells for implantable defibrillator devices—Discharge voltage models
Published in Journal of power sources (01-08-2010)“…The discharge potential behavior of lithium-manganese dioxide cells designed for implantable cardiac defibrillators was characterized as a function of extent…”
Get full text
Journal Article -
17
Site-Specific Polymer Attachment to HR2 Peptide Fusion Inhibitors against HIV‑1 Decreases Binding Association Rates and Dissociation Rates Rather Than Binding Affinity
Published in Bioconjugate chemistry (15-03-2017)“…A popular strategy for overcoming the limited plasma half-life of peptide heptad repeat 2 (HR2) fusion inhibitors against HIV-1 is conjugation with…”
Get full text
Journal Article -
18
Protein Design of an HIV-1 Entry Inhibitor
Published in Science (American Association for the Advancement of Science) (02-02-2001)“…Human immunodeficiency virus type-1 (HIV-1) membrane fusion is promoted by the formation of a trimer-of-hairpins structure that brings the amino- and…”
Get full text
Journal Article -
19
Implantable Cardiac Rhythm Device Batteries
Published in Journal of cardiovascular translational research (01-12-2008)“…Batteries used for implantable cardiac rhythm devices are described herein. Fully implanted cardiac rhythm devices, pacemakers, and defibrillators treat…”
Get full text
Journal Article -
20
HIV-1 gp41 as a target for viral entry inhibition
Published in Current pharmaceutical design (01-01-2004)“…The recent success of the fusion inhibitor T-20 (enfuvirtide) in clinical studies has ushered in a new chapter in the development of anti-HIV-1 therapeutics…”
Get more information
Journal Article